Vobarilizumab [1628814-88-9]

TargetMol Chemicals

Vobarilizumab

9

1628814-88-9

Antibody

Research Use Only

Vobarilizumab

Vobarilizumab (ALX-0061) is a monoclonal antibody (mAb) targeting the IL-6 receptor (IL-6R) with a dissociation constant (Kd) of 0.19 pM, indicating high affinity for its target. This compound features both an anti-IL-6R domain and an anti-human serum albumin domain, making it a potential research tool for investigating inflammatory autoimmune diseases like rheumatoid arthritis [1] [2] [3].

3 years

-20°C

12352203